Correlating Quantitative MR Imaging with Histopathology in X-Linked Adrenoleukodystrophy

References

1. 1.↵
   1. Van der Voorn JP,
   2. Pouwels PJ,
   3. Hart AA,
   4. et al

   . Childhood white matter disorders: quantitative MR imaging and spectroscopy. Radiology 2006;241:510–17

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Van der Knaap MS,
   2. Valk J

   . MR of adrenoleukodystrophy: histopathologic correlations. AJNR Am J Neuroradiol 1989;10:S12–14

   PubMed
3. 3.↵
   1. Powers JM

   . Demyelination in peroxisomal diseases. J Neurol Sci 2005;15:206–07. Epub 2004 Dec 2
4. 4.↵
   1. Schmierer K,
   2. Tozer DJ,
   3. Scaravilli F,
   4. et al

   . Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging 2007;26:41–51

   CrossRefPubMedWeb of Science
5. 5.↵
   1. van Waesberghe JH,
   2. Kamphorst W,
   3. De Groot CJ,
   4. et al

   . Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747–54

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Bitsch A,
   2. Bruhn H,
   3. Vougioukas V,
   4. et al

   . Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–27

   Abstract/FREE Full Text
7. 7.↵
   1. Schmierer K,
   2. Wheeler-Kingshott CA,
   3. Boulby PA,
   4. et al

   . Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007;35:467–77. Epub 2006 Dec 16

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Seewann A,
   2. Vrenken H,
   3. van der Valk P,
   4. et al

   . Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol 2009;66:601–09

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Provencher SW

   . Estimation of metabolite concentrations from localized in vivo proton MR spectra. Magn Reson Med 1993;30:672–79

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Pouwels PJ,
    2. Brockmann K,
    3. Kruse B,
    4. et al

    . Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999;46:474–85

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Jones DK,
    2. Horsfield MA,
    3. Simmons A

    . Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999;42:515–25

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Geurts JJ,
    2. Bö L,
    3. Pouwels PJ,
    4. et al

    . Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005;26:572–77

    Abstract/FREE Full Text
13. 13.↵
    1. Le Bihan D,
    2. Poupon C,
    3. Amadon A,
    4. et al

    . Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006;24:478–88

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Koch MA,
    2. Glauche V,
    3. Finsterbusch J,
    4. et al

    . Distortion-free diffusion tensor imaging of cranial nerves and of inferior temporal and orbitofrontal white matter. Neuroimage 2002;17:497–506

    CrossRefPubMed
15. 15.↵
    1. Vrenken H,
    2. Pouwels PJ,
    3. Geurts JJ,
    4. et al

    . Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 2006;23:628–36

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Mottershead JP,
    2. Schmierer K,
    3. Clemence M,
    4. et al

    . High field MRI correlates of myelin content and axonal density in multiple sclerosis: a post-mortem study of the spinal cord. Neurology 2003;250:1293–301

    CrossRef
17. 17.↵
    1. Graham SJ,
    2. Stanisz GJ,
    3. Kecojevic A,
    4. et al

    . Analysis of changes in MR properties of tissues after heat treatment. Magn Reson Med 1999;42:1061–71

    CrossRefPubMed
18. 18.↵
    1. Schmierer K,
    2. Wheeler-Kingshott CA,
    3. Tozer DJ,
    4. et al

    . Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med 2008;59:268–77

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Thelwall PE,
    2. Shepherd TM,
    3. Stanisz GJ,
    4. et al

    . Effects of temperature and aldehyde fixation on tissue water diffusion properties, studied in an erythrocyte ghost tissue model. Magn Reson Med 2006;56:282–89

    CrossRefPubMed
20. 20.↵
    1. Shepherd TM,
    2. Flint JJ,
    3. Thelwall PE,
    4. et al

    . Postmortem interval alters the water relaxation and diffusion properties of rat nervous tissue: implications for MRI studies of human autopsy samples. Neuroimage 2009;44:820–26

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Van der Knaap MS

    . Magnetic resonance in childhood white-matter disorders. Dev Med Child Neurol 2001;43:705–12

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Pouwels PJ,
    2. Kruse B,
    3. Korenke GC

    . Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 1998;29:254–64

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Confort-Gouny S,
    2. Vion-Dury J,
    3. Chabrol B,
    4. et al

    . Localised proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy. Neuroradiology 1995;37:568–75

    PubMedWeb of Science
24. 24.↵
    1. Hattingen E,
    2. Raab P,
    3. Franz K,
    4. et al

    . Myo-inositol: a marker of reactive astrogliosis in glial tumors? NMR Biomed 2008;21:233–41

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Eichler FS,
    2. Itoh R,
    3. Barker PB,
    4. et al

    . Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 2002;225:245–52

    PubMedWeb of Science
26. 26.↵
    1. Eichler FS,
    2. Barker PB,
    3. Cox C,
    4. et al

    . Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology 2002;58:901–07

    Abstract/FREE Full Text
27. 27.↵
    1. Ith M,
    2. Bigler P,
    3. Scheurer E,
    4. et al

    . Observation and identification of metabolites emerging during postmortem decomposition of brain tissue by means of in situ 1H-magnetic resonance spectroscopy. Magn Reson Med 2005;48:915–20

    CrossRef
28. 28.↵
    1. Symms M,
    2. Jager HR,
    3. Schmierer K,
    4. et al

    . A review of structural magnetic resonance neuroimaging. J Neurol Neurosurg Psychiatry 2004;75:1235–44

    Abstract/FREE Full Text
29. 29.↵
    1. Bizzi A,
    2. Castellit G,
    3. Bugiani M,
    4. et al

    . Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 29;1270–75
30. 30.↵
    1. Schmierer K,
    2. Scaravilli F,
    3. Altmann DR,
    4. et al

    . Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407–15

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Horsfield MA,
    2. Barker GJ,
    3. Barkhof F,
    4. et al

    . Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J Magn Res Imaging 2003;17:389–97

    CrossRefPubMedWeb of Science